Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

Order by stock part number »
Get Help
 |  EN
Sign In
ProcessingProcessing

Overcome cancer research challenges with NGS solutions

Overcome cancer research challenges with NGS solutions

Overcome cancer research challenges with IDT's tailored solutions. Join this webinar to learn how we can assist in your unique workflow needs.

In this webinar, you will:

  • Explore the varied IDT xGen NGS solutions for oncology research, including whole genome sequencing (WGS), whole exome sequencing (WES), methylation sequencing (methyl-seq), RNA sequencing (RNA-seq), and more!
  • Discover which IDT solutions provide the workflow flexibility your research requires.
  • Experience xGen NGS offerings for library preparation, adapters and primers, library normalization, and target enrichment.

Published on: October 06, 2022

Categories:
Next generation sequencing Whole Exome Sequencing Whole genome sequencing Cancer Cancer Research Cancer liquid biopsy Cancer tumor profiling Tumor Mutational Burden (TMB) & microsatellite instability (MSI) Webinar Whole genome sequencing

*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.